Screening for minimal hypothyroidism. How sensitive is the free thyroxine assay?

Area of Science:

• Endocrinology
• Clinical Chemistry
• Thyroid Function Testing

Background:

• Accurate screening for minimal hypothyroidism is crucial for timely intervention.
• Traditional methods like the free thyroxine index (FTI) are widely used.
• Newer assays, such as free thyroxine (FT4), are available for thyroid function assessment.

Purpose of the Study:

• To compare the sensitivity of the free thyroxine (FT4) assay against the free thyroxine index (FTI).
• To evaluate their effectiveness in screening patients for minimal thyroid dysfunction.
• To assess agreement with clinical evaluation, particularly in patients with varying thyroid-stimulating hormone (TSH) responses.

Main Methods:

• A comparative study involving 98 consecutive patients.
• Evaluation of free thyroxine index (FTI) and free thyroxine (FT4) assay results.
• Comparison with the thyrotropin-releasing hormone (TRH) stimulation test and clinical assessment.

Main Results:

• FTI and FT4 values showed disagreement with clinical evaluation in 20% of patients with transitional TSH response (21-35 microU/ml).
• A higher disagreement rate of 64.3% was observed for FTI and FT4 in patients with augmented TSH response (>35 microU/ml).
• Neither the FT4 assay nor the FTI demonstrated superior sensitivity in identifying minimal thyroid dysfunction.

Conclusions:

• The free thyroxine (FT4) assay offers no significant advantage in sensitivity over the free thyroxine index (FTI) for detecting minimal hypothyroidism.
• Both FTI and FT4 assays exhibit limitations in screening patients with subtle thyroid function abnormalities.
• Further research may be needed to identify more sensitive biomarkers or refine existing testing protocols for early hypothyroidism detection.